CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathwaysKiyoko Nakamura, Masahide Ohmichi, Yoshito Terai et al.|Oncology Reports|2017Cited by 117
The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancerMasaaki Takai, Masahide Ohmichi, Satoe Fujiwara et al.|Journal of Ovarian Research|2014Cited by 108
Total laparoscopic modified radical hysterectomy with lymphadenectomy for endometrial cancer compared with laparotomyYoshito Terai, Masahide Ohmichi, Tomohito Tanaka et al.|Journal of obstetrics and gynaecology research|2013Cited by 32
The detection of sentinel lymph nodes in laparoscopic surgery can eliminate systemic lymphadenectomy for patients with early stage endometrial cancerTomohito Tanaka, Masahide Ohmichi, Yoshito Terai et al.|International Journal of Clinical Oncology|2017Cited by 31
CD24 expression as a marker for predicting clinical outcome and invasive activity in uterine cervical cancerTomohito Tanaka, Masahide Ohmichi, Yoshito Terai et al.|Oncology Reports|2015Cited by 29